Hot Pursuit     13-Sep-23
Zydus Life rises after receiving EIR report for Ahmedabad-based facility from US FDA
Zydus Lifesciences added 1.90% to Rs 639.60 after the company announced the receipt of EIR report from the USFDA for the inspection conducted at the injectables manufacturing facility at Zydus Biotech Park, Changodar, Ahmedabad.

The inspection, carried out between 5th and 13th of June 2023, was a cGMP Inspection and had ended with NIL observations.

Zydus Lifesciences is a discovery-driven, global lifesciences company that discovers, develops, manufactures, and markets a broad range of healthcare therapies.

The company had reported 109.7% surge in net profit to Rs 1,086.9 crore in Q1 FY24 as compared with Rs 518.3 crore posted in Q1 FY23. Revenue from operations jumped 29.6% to Rs 5,139.6 crore during the quarter as compared with Rs 3,964.4 crore recorded in same quarter last year.

Previous News
  Zydus Lifesciences receives EIR for facility at Jarod, Vadodara
 ( Corporate News - 04-Dec-25   15:48 )
  Zydus Life gets US FDA nod for generic version of antidiabetic combination drug Glyxambi
 ( Hot Pursuit - 28-Nov-25   09:21 )
  Zydus Life rises after inking exclusive licensing deal with RK Pharma for US oncology product
 ( Hot Pursuit - 26-Nov-25   13:30 )
  Zydus enters into licensing and commercialization agreement with RK Pharma Inc.
 ( Corporate News - 26-Nov-25   13:15 )
  Zydus Lifesciences Ltd rises for third consecutive session
 ( Hot Pursuit - 26-Nov-25   13:05 )
  Stock Alert: Zydus Lifescience, United Breweries, Nelco, NCC, Refex Inds
 ( Market Commentary - Stock Alert 26-Nov-25   07:50 )
  Zydus receives USFDA approval for Verapamil Hydrochloride Extended-Release Tablets
 ( Corporate News - 25-Nov-25   19:30 )
  Zydus Lifesciences
 ( Analyst Meet / AGM - Conference Call 18-Nov-25   12:13 )
  Zydus receives USFDA approval for Leuprolide Acetate injection
 ( Corporate News - 14-Nov-25   18:49 )
  Zydus receives China NMPA approval for Venlafaxine ER Capsules
 ( Corporate News - 11-Nov-25   10:09 )
  Zydus Lifesciences gets USFDA tentative Nod for Olaparib Tablets
 ( Hot Pursuit - 10-Nov-25   09:29 )
Other Stories
  HFCL secures Rs 656 crore export orders for optical fiber cables
  06-Dec-25   17:23
  Ashoka Buildcon secures Rs 447 crore order from BMC
  06-Dec-25   16:01
  InterGlobe Aviation feels heat from IndiGo disruptions
  06-Dec-25   15:53
  MTAR Technologies bags Rs 194 crore order from MEIL
  06-Dec-25   14:31
  Atishay wins Rs 93 lakh order from Rajasthan cooperative bank
  06-Dec-25   13:09
  BMW Ventures secures Rs 6-cr job-work order
  06-Dec-25   12:25
  ACS Technologies secures orders worth Rs 6 crore from Indian Navy
  06-Dec-25   11:21
  ICICI Bank says ICICI Prudential AMC files RHP for IPO
  06-Dec-25   09:53
  Dynamatic Technologies, Dassault ink deal for Falcon 6X rear fuselage
  06-Dec-25   09:33
  Hindustan Unilever drops as Kwality Wall’s demerger takes effect
  05-Dec-25   15:29
Back Top